News

 

Clayton, Dubilier & Rice to Invest in PharMEDium, Nation’s Leading Provider of Sterile Compounding Services to Hospital Pharmacies

PharMEDium, the leading national provider of hospital pharmacy-outsourced sterile compounding services, today announced an agreement under which a fund managed by Clayton, Dubilier & Rice (CD&R) will invest in the company. Oak Investment Partners and Baird Capital will exit as part of the transaction, while JVC Management, an investment firm controlled by David N. Jonas, Chairman and CEO of the Company, will retain an investment in the company. More...